world
Suntory to Acquire Daiichi Sankyo Healthcare for 246.5 Billion Yen
Suntory has started buying Daiichi Sankyo Healthcare for ¥246.5 billion. The Japanese beverage company will take full ownership in about three years to expand into over-the-counter drugs and self-care products.
Jul 7, 2:17 AM·1m read1 source
forbes.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Suntory has begun acquiring Daiichi Sankyo Healthcare, an over-the-counter drugmaker, for ¥246.5 billion ($1.5 billion), The Japan Times reported on July 7, 2026. The company will own 100 percent of Daiichi Sankyo Healthcare within about three years.
The move is intended to offset possible weakness in Suntory’s core beverage operations and to benefit from rising demand for self-care products, according to The Japan Times.
Suntory is also acquiring the business to enter the health foods and OTC pharmaceuticals sector. Toru Miyanaga, Suntory’s chief strategy officer, said last week that the company aims to roughly double sales over the next 10 years through synergy and growth of existing products related to Daiichi Sankyo Healthcare.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationModerate · 1 source
